Clinical Trial, Phase 1
1 clinical trials · Condition
◉ Watch Clinical Trial, Phase 1
| Record | Firm | Date |
|---|---|---|
| A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. (NCT00676299) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-08-01 |
Track Clinical Trial, Phase 1 automatically
Every clearance here is in the API, with alerts when new ones post.